Trials / Conditions / Lymphoid Hematological Malignancies
Lymphoid Hematological Malignancies
5 registered clinical trials studyying Lymphoid Hematological Malignancies — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR NCT07472972 | University of Zurich | — |
| Unknown | Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurren NCT04626908 | He Huang | Phase 1 / Phase 2 |
| Recruiting | A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies NCT04283006 | He Huang | EARLY_Phase 1 |
| Terminated | A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies NCT02223598 | Cleave Biosciences, Inc. | Phase 1 |
| Withdrawn | Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies NCT01247688 | Baylor College of Medicine | N/A |